Support By : Li-lab
| GENE_SYMBOL | HGNC_ID | UNIPROT_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| TIE1 | HGNC:11809 | P35590 | Tozasertib | 5494449 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Pelitinib | 6445562 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Axitinib | 6450551 | DSigDB, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Midostaurin | 9829523 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Neratinib | 9915743 | Pubchem |
| TIE1 | HGNC:11809 | P35590 | Cediranib | 9933475 | Pubchem |
| TIE1 | HGNC:11809 | P35590 | Pazopanib | 10113978 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | 1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl- | 10138259 | Pubchem |
| TIE1 | HGNC:11809 | P35590 | (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide | 11152667 | DSigDB |
| TIE1 | HGNC:11809 | P35590 | Brivanib | 11234052 | Pubchem |
| TIE1 | HGNC:11809 | P35590 | Ast-487 | 11409972 | ChemBL |
| TIE1 | HGNC:11809 | P35590 | Kw-2449 | 11427553 | Pubchem |
| TIE1 | HGNC:11809 | P35590 | Linifanib | 11485656 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Barasertib | 11497983 | DSigDB |
| TIE1 | HGNC:11809 | P35590 | Crizotinib | 11626560 | DSigDB, Pubchem |
| TIE1 | HGNC:11809 | P35590 | Raf-265 | 11656518 | ChemBL, Pubchem |
| TIE1 | HGNC:11809 | P35590 | FOSTAMATINIB | 11671467 | DrugBank |
| TIE1 | HGNC:11809 | P35590 | AZ-628 | 11676786 | DSigDB |
| TIE1 | HGNC:11809 | P35590 | 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid | 11712649 | ChemBL, DSigDB, Pubchem |
| TIE1 | HGNC:11809 | P35590 | BX-912 | 11754511 | DSigDB |